## Summary
This paper proposes INSITE, a method that connects ODE discovery (using SINDy) to longitudinal heterogeneous treatment effects inference. The core idea is to discover closed-form equations instead of training neural-network-based inference machines, yielding interpretable dynamics. The paper identifies three discrepancies between the two fields (assumptions, treatment types, between-subject variability) and instantiates a two-step procedure: population-level ODE discovery followed by patient-specific fine-tuning of numeric constants.

## Strengths
- **Genuinely novel paradigm for treatment effects inference.** The paper proposes a fundamentally different type of solution — discovering closed-form ODEs rather than black-box neural networks (lines 10–14). This is a clear departure from the dominant paradigm and opens a new direction.
- **Consistent empirical outperformance across all 9 synthetic datasets.** In Table 1 (lines 957–968), INSITE achieves the lowest counterfactual n-RMSE on every dataset. On well-specified one-compartment PKPD datasets the advantage is dramatic (0.02–0.05 vs. 0.72–2.09 for LTE methods). On misspecified tumor-growth datasets the advantage is more modest but consistent (0.79–0.94 vs. 0.92–1.05 for the best LTE method, CRN).
- **Ablation study validates both design choices.** The ablation (lines 984–998) shows that removing per-category ODEs degrades n-RMSE from 0.05 to 0.43 and removing fine-tuning degrades it to 0.15, confirming both components contribute.
- **Interpretable equation recovery demonstrated.** The paper shows that INSITE can recover exact or near-exact ODE forms in simple settings (lines 749–751), which neural-network baselines cannot provide.

## Weaknesses

### Fatal
None.

### Major
- **The evaluation narrative treats well-specified and misspecified settings uniformly, inflating the perceived strength of the evidence.** On the one-compartment PKPD datasets (where ODE discovery methods are correctly specified), INSITE achieves near-perfect recovery (n-RMSE 0.02–0.05) while LTE methods score 0.72–2.09. This massive gap is expected — the LTE methods are not designed to exploit ODE structure. The more informative comparison is on the Cancer PKPD and eq:tumor datasets where ODE discovery methods are **misspecified** (the feature library lacks log terms, as acknowledged at lines 753–754). Here INSITE's advantage over the best LTE method is 14–20% (0.79 vs. 0.92). The paper's narrative (line 747: "INSITE achieves the lowest test counterfactual normalized RMSE across all methods") treats these qualitatively different results uniformly, which obscures what the evaluation actually demonstrates.

- **The overlap relaxation claim is experimentally tested under misspecification, contradicting the theoretical argument.** The paper argues (lines 464–471) that correct model specification (via existence/uniqueness + functional space restriction) can substitute for the overlap assumption. However, the empirical demonstration (Figure 2b, lines 863–937) is conducted on the Cancer PKPD dataset where INSITE is **misspecified** — the feature library does not contain the log terms required for the tumor growth equation (line 753). The theoretical argument is about *correct* specification enabling extrapolation, but the experiment tests *incorrect* specification. This contradiction is not acknowledged or discussed. The experiment shows graceful degradation under misspecification (from ~0.84 at γ=0 to ~1.10 at γ=4), which is an interesting finding about robustness, but it is not a demonstration of the theoretical claim about correctly-specified ODEs relaxing overlap.

- **Near-zero confidence intervals for INSITE and A-SINDy require explanation.** In Table 1, INSITE's 95% CIs on the one-compartment PKPD datasets are essentially zero (e.g., ±2.62e-18, ±0.00, ±5.23e-18). A-SINDy shows the same pattern, while LTE methods show substantial variance (±0.10 to ±0.24). The paper states results are "averaged over ten random seed runs" (line 949) but does not specify which sources of randomness vary across seeds. If ODE discovery (SINDy + BFGS) is deterministic and the seeds only affect network initialization for LTE methods (not data splits or noise realizations), then the CIs are not comparable. The paper must clarify whether the same 10 data realizations are used for all methods and whether the near-zero variance reflects genuine stability or incomplete randomization.

- **Missing baseline from the continuous-time treatment effects literature.** The paper cites Seedat et al. (2022) for the treatment intensity process assumptions and the Cancer PKPD dataset but does not include TE-CDE (the method from that work) as a baseline. TE-CDE uses controlled differential equations and is the most directly comparable continuous-time TE method. The paper's motivation that existing solutions are "neural-network-based inference machines" (line 10) contrasts with TE-CDE, which is CDE-based rather than a standard RNN-based approach. Including this baseline would substantially strengthen — or challenge — the paper's positioning. Without it, the claim of offering a "completely new type of solution" (line 14) is not fully evaluated against the closest alternative.

### Minor
- **The framework contribution and the INSITE method are partially conflated.** The paper claims (lines 15, 46) that the primary contribution is a "framework that can transform any ODE discovery method into a treatment effects method," yet only one instantiation (INSITE) is evaluated. The adapted baselines (A-SINDy, A-WSINDy) incorporate some framework components but are not presented as framework demonstrations. A second demonstration with a different ODE discovery method would substantiate the framework claim.
- **No wall-clock time or compute cost reported.** ODE discovery via SINDy + per-patient BFGS optimization could be much faster or much slower than neural-network methods; readers cannot judge the practical trade-off.
- **The overlap relaxation argument lacks formal development.** The claim that "overlap can be relaxed with existence/uniqueness and functional space restriction" (lines 466, Table 1) is stated without formal justification or precise conditions. A formal statement would significantly strengthen the paper.

### Trivial
None.

## Nice-to-Haves
- Foreground the misspecified-settings results as the primary evidence for real-world applicability, with the well-specified results as proof-of-concept.
- Add TE-CDE as a baseline, or explain clearly why it was excluded.
- Report wall-clock time or FLOPs to help practitioners assess practical cost.
- Provide a formal statement of the conditions under which the overlap assumption can be relaxed for ODE-discovery-based methods.

## Removed Points
These points were raised by reviewers but removed after verification against the paper:
- **Harsh critic's "linear regression vs. neural network" analogy** — overstates the case. The one-compartment PKPD datasets include noise, four BSV layers (A–D), and time-dependent confounding, making the recovery non-trivial.
- **Criticism that the framework is not truly a framework** — the paper is sufficiently clear that INSITE is an instantiation (line 452), though a second demonstration would strengthen the claim.
- **Complaints about synthetic data details being in the appendix** — standard practice for benchmarking papers.
- **Strength finder's claim that the framework is "actionable" and "immediately usable"** — the action items are high-level design considerations, not a precise recipe, making this claim inflated.
- **Generic "problem is important" strength** — removed as it lacks specific evidence from the paper.

## Novel Insights
The most valuable insight from the reviews is the tension between the paper's theoretical overlap-relaxation claim and its experimental demonstration. The paper argues that correct model specification permits overlap violation, yet the experiment showing this is conducted under **misspecification** (Cancer PKPD, where the feature library lacks log terms). This contradiction is not accidental — INSITE degrades more gracefully than LTE methods even when misspecified, but for reasons the paper does not theorize. Understanding *why* a misspecified ODE-based method still extrapolates reasonably well under high confounding (perhaps the sparse functional form imposes a strong inductive bias) would be a stronger contribution than the current framing, which claims a theoretical guarantee but provides an empirical observation.

The zero-variance CI issue, while not necessarily fatal, reveals a deeper question: confidence intervals are not comparable across methods when the randomness structure differs qualitatively (deterministic ODE optimization vs. stochastic neural network training). The paper should either make the randomization procedure transparent or use a comparison method that accounts for this asymmetry.

## Suggestions
1. Restructure the evaluation to clearly separate well-specified and misspecified settings, leading with the latter as the primary evidence.
2. Acknowledge the tension between the overlap relaxation theoretical claim and its misspecified experimental demonstration; discuss what graceful degradation under misspecification implies about the method's inductive biases.
3. Add TE-CDE as a baseline, or explain why it was excluded.
4. Clarify the variance reporting: state which sources of randomness are varied across the ten seeds, and show that the near-zero CIs are not artifacts of incomplete randomization.
5. Provide a formal statement of conditions under which the overlap assumption can be relaxed, or temper the claim to match what is empirically shown (robustness under misspecification).

## Score and Decision
MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>